—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) — Technical state

As of 2026-10-15 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

Uptrend stack intact

Trades +3.8% vs the 50-day and +25.6% vs the 200-day average, 9.1% below the 52-week high and +101.4% off the 52-week low. Computed from daily closes.

Ranked #48 on today’s Directional Flow — Getting stronger list (scan of 2026-10-15).

The moving-average stack

Continue: the AMRX chart & overview · the earnings record · the signal board

FAQ · from the current data · as of 2026-10-15

Quick answers

What is the current Closelooknet signal on AMRX?

Uptrend stack intact — Trades +3.8% vs the 50-day and +25.6% vs the 200-day average, 9.1% below the 52-week high and +101.4% off the 52-week low. Computed from daily closes. As of 2026-10-15; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is AMRX above its 50-day and 200-day moving averages?

As of 2026-10-15, Amneal Pharmaceuticals, Inc. Class A Common Stock trades +3.8% above its 50-day and +25.6% above its 200-day average, with the 20-day -2.8% away.

How far is AMRX from its 52-week high?

9.1% below the 52-week high and 101.4% above the 52-week low, as of 2026-10-15.

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.